Synthesis
Tetraethylammonium NVOC-leucine ethyl phosphate (1). A round bottom flask was charged with α-NVOC-leucine (170 mg, 0.46 mmol) and N,N'-dicyclohexylcarbodiimide (94 mg, 0 .46 mmol) in 10 mL of dry CH 2 Cl 2 . Reaction allowed to stir for 10 minutes at room temperature. A separately prepared solution of bis(tetraethylammonium) ethyl phosphate (175 mg, 0.46 mmol) in 10 mL dry CH 2 Cl 2 was added via syringe. Reaction allowed to stir for 4 hours at room temperature. The reaction mixture was concentrated and resuspended in 5 mL of CH 2 Cl 2 . Upon filtration, the organic solution was extracted three times with 5 mL of water. Saturated NaCl solution was added dropwise to aid in emulsion breaking. The combined aqueous extracts were washed with 5 mL CHCl 3 followed by lyophilization. 169.62, 155.57, 154.01, 147.91, 139.09, 128.76, 109.53, 107.99, 63.35, 61.81, 61.76, 56.80, 56.43, 53.62, 53.58, 52.59, 41.35, 24.82, 23.08, 21.61, 16.64, 16.58, Tetraethylammonium N-NVOC-tyrosine ethyl phosphate (2). A round bottom flask was charged with α-NVOC-tyrosine (150 mg, 0.36 mmol) and N,N'-dicyclohexylcarbodiimide (147 mg, 0.71 mmol) in 1.5 mL of dry THF and 1 mL of dry CH 2 Cl 2 . Reaction allowed to stir for 4 minutes at room temperature. A separately prepared solution of bis(tetraethylammonium) ethyl phosphate (91 mg, 0.24 mmol) in 4 mL dry CH 2 Cl 2 was added via syringe. Reaction allowed to stir for 19 hours at room temperature. The reaction mixture was filtered, and extracted three times with 5 mL of water. Saturated NaCl solution was added dropwise to aid in emulsion breaking. The combined aqueous extracts were lyophilized. The resulting solid was extracted with acetonitrile and filtered. Concentration of the acetonitrile solution gave a yellow oil 92 mg (63 %). Analytical sample obtained by reverse phase HPLC.
1 H NMR (300 MHz, CD 3 CN) δ 8.93 (br, 1H), 7.69 (s, 1H), 7.07 (d, J = 8.6 Hz, 3H), 6.78 (d, J = 8.5 Hz, 2H), 6.13 (d, J = 8.5 Hz, 1H), 5.39 (s, 2H), 4.44 -4.32 (m, 1H), 4.05 -3.79 (m, J = 12.5, 5.1 Hz, 8H), 3.18 (q, J = 7.3 Hz, 8H), 3.14 -3.05 (m, 1H), 2.99 -2.84 (m, 1H), 1.28 -1.15 (m, 15H).
13 C NMR (126 MHz, CD 3 CN) δ 168. 88, 168.80, 157.53, 155.99, 154.27, 147.96, 139.02, 130.28, 128.93, 127.23, 117.50, 115.60, 109.63, 108.09, 62.96, 61.45, 61.40, 57.13, 56.62, 56.00, 52.24, 52.22, 52.19, 35.89, 16.18, 16.12, 6 .93. Tetraethylammonium NVOC-tryptophan ethyl phosphate (3). A round bottom flask was charged with α-NVOC-tryptophan (107 mg, 0.24 mmol) and N,N'-dicyclohexylcarbodiimide (50 mg, 0.24 mmol) in 6 mL of dry THF. Reaction allowed to stir for 10 minutes. A separately prepared solution of bis(tetraethylammonium) ethyl phosphate (93 mg, 0.25 mmol) in 5 mL CH 2 Cl 2 was then added via syringe. Reaction allowed to stir overnight at room temperature. The reaction mixture was concentrated on a rotary evaporator and resuspended in 2.5 mL of CH 2 Cl 2 . Filtration of the suspension gave an organic solution that was extracted three times with 2 mL of water. Combined aqueous extracts were washed with 2 mL of CHCl 3 followed by lyophilization to give a yellow foam, 87.9 mg (55% 76, 168.63, 155.30, 153.81, 148.02, 139.33, 136.58, 128.41, 128.36, 125.17, 120.96, 118.74, 117.72, 112.43, 110.09, 108.07, 107.85, 77.45, 77.02, 76.60, 63.40, 62.13, 62.04, 56.60, 56.39, 52.25, 27.15, 16.68, 16.58, 7.25 . 75, 168.68, 158.52, 156.67, 155.32, 153.79, 148.02, 139.42, 133.12, 128.51, 128.44, 128.12, 127.17, 113.18, 113.11, 110.08, 109.25, 109.04, 108.02, 107.84, 107.81, 102.35, 102.16, 63.52, 62.19, 62.14, 56.53, 56.37, 52.23, 27.08, 16.62, 16.56, 7.23 
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Supplemental Figure 1 MALDI mass spectra of THG73 tRNA after (below) exposure to La 3+ mediated acylation conditions using tyrosine derivative 2 (top), tryptophan derivative 3 (middle), and flurotryptophan derivative 4 (bottom). Observed masses shown, theoretical masses in parentheses. Based on calibration data, we estimate the yields at 15%, 10%, and 5% for 2, 3, and 4, respectively.
